AuroLase Therapy

DEVICE2 trials

Sponsors

Nanospectra Biosciences, Inc.

Conditions

Head and Neck CancerPrimary or Metastatic Lung Tumors

Unknown Phase

Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck

CompletedNCT00848042

Nanospectra Biosciences, Inc.Head and Neck Cancer

Start: 2008-04-30End: 2014-08-31Updated: 2017-02-09

Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors

TerminatedNCT01679470

Nanospectra Biosciences, Inc.Primary or Metastatic Lung Tumors

Start: 2012-10-31End: 2014-06-30Updated: 2016-11-03